Category Archives: Federal Drug Administration

Which Persons Are At Increased Risk When Exposed To COVID-19 Infected Persons And Why It Matters: Links To And Excerpts From The “FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF REGEN-COVTM (casirivimab and imdevimab)” From The FDA

In this post I link to and excerpt from the FACT SHEET FOR HEALTH CARE PROVIDERS: EMERGENCY USE AUTHORIZATION (EUA) OF REGEN-COVTM (casirivimab and imdevimab) [Link is to the 56 page full PDF].  From the Federal Drug Administration. The above … Continue reading

Posted in COVID-19, COVID-19 Treatment, Federal Drug Administration | Comments Off on Which Persons Are At Increased Risk When Exposed To COVID-19 Infected Persons And Why It Matters: Links To And Excerpts From The “FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF REGEN-COVTM (casirivimab and imdevimab)” From The FDA